{ "company_number": "08346259", "name": "GC Biosciences Ltd", "url": "/company/08346259", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2013-01-03", "dissolved_on": null, "sic_codes": [ { "code": "86900", "description": "Other human health activities", "section": "Q", "section_name": "Human health and social work activities", "url": "/sic/86900" } ], "registered_address": { "id": 2789573, "url": "/address/2789573", "line1": "124 CITY ROAD", "line2": "", "post_town": "LONDON", "county": "", "country": "UNITED KINGDOM", "postcode": "EC1V 2NX" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/08346259", "previous_names": [ { "name": "Gore Bioscience Ltd", "ceased_on": "2015-08-11" } ], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2026-12-31", "last_made_up": "2025-03-31", "category": "TOTAL EXEMPTION FULL", "filings": [ { "url": "/company/08346259/accounts/2025-03-31", "made_up_date": "2025-03-31", "period_start": "2025-03-31", "period_end": "2025-03-31", "entity_name": "GC Biosciences Ltd", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": "4351.00", "debtors": "113694.00", "cash_bank_in_hand": "2798.00", "current_assets": "116492.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "54235.00", "total_assets_less_current_liabilities": "58586.00", "net_assets_liabilities": "20316.00", "called_up_share_capital": "2000.00", "profit_loss_account_reserve": "18316.00", "shareholder_funds": "2000.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2025.zip" }, { "url": "/company/08346259/accounts/2024-03-31", "made_up_date": "2024-03-31", "period_start": "2024-03-31", "period_end": "2024-03-31", "entity_name": "Gc Biosciences Ltd", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": "5802.00", "debtors": "125455.00", "cash_bank_in_hand": "840.00", "current_assets": "126295.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "58161.00", "total_assets_less_current_liabilities": "63963.00", "net_assets_liabilities": "20396.00", "called_up_share_capital": "2000.00", "profit_loss_account_reserve": "18396.00", "shareholder_funds": "2000.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2025.zip" }, { "url": "/company/08346259/accounts/2023-01-31", "made_up_date": "2023-01-31", "period_start": "2023-01-31", "period_end": "2023-01-31", "entity_name": "G C Biosciences Ltd", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": "9743.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "86809.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "36980.00", "total_assets_less_current_liabilities": "46723.00", "net_assets_liabilities": "2556.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "2556.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2023.zip" }, { "url": "/company/08346259/accounts/2022-01-31", "made_up_date": "2022-01-31", "period_start": "2022-01-31", "period_end": "2022-01-31", "entity_name": "G C Biosciences Ltd", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "14330.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "95179.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "44915.00", "total_assets_less_current_liabilities": "59245.00", "net_assets_liabilities": "62.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "62.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2022.zip" }, { "url": "/company/08346259/accounts/2021-01-31", "made_up_date": "2021-01-31", "period_start": "2021-01-31", "period_end": "2021-01-31", "entity_name": "G C Biosciences Ltd", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "19777.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "101661.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "50055.00", "total_assets_less_current_liabilities": "69832.00", "net_assets_liabilities": "49.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "49.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2021.zip" }, { "url": "/company/08346259/accounts/2020-01-31", "made_up_date": "2020-01-31", "period_start": "2020-01-31", "period_end": "2020-01-31", "entity_name": "G C Biosciences Ltd", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "26370.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "68980.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "18121.00", "total_assets_less_current_liabilities": "44491.00", "net_assets_liabilities": "12691.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "12691.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2020.zip" }, { "url": "/company/08346259/accounts/2019-01-31", "made_up_date": "2019-01-31", "period_start": "2019-01-31", "period_end": "2019-01-31", "entity_name": "G C Biosciences Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "6993.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "120983.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "45602.00", "total_assets_less_current_liabilities": "52595.00", "net_assets_liabilities": "52595.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "52595.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2019.zip" }, { "url": "/company/08346259/accounts/2018-01-31", "made_up_date": "2018-01-31", "period_start": "2018-01-31", "period_end": "2018-01-31", "entity_name": "G C Biosciences Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "9324.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "84928.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "43653.00", "total_assets_less_current_liabilities": "52977.00", "net_assets_liabilities": "52977.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "52977.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2018.zip" }, { "url": "/company/08346259/accounts/2017-01-31", "made_up_date": "2017-01-31", "period_start": "2017-01-31", "period_end": "2017-01-31", "entity_name": "GC Biosciences Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "12432.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "87140.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-969.00", "total_assets_less_current_liabilities": "11463.00", "net_assets_liabilities": "11463.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "11463.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2017.zip" }, { "url": "/company/08346259/accounts/2016-01-31", "made_up_date": "2016-01-31", "period_start": "2016-01-31", "period_end": "2016-01-31", "entity_name": "GC Biosciences Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "16576.00", "debtors": "69641.00", "cash_bank_in_hand": "46.00", "current_assets": "69716.00", "creditors_due_within_one_year": "54109.00", "creditors_due_after_one_year": "28698.00", "net_current_assets_liabilities": "15607.00", "total_assets_less_current_liabilities": "32183.00", "net_assets_liabilities": "3485.00", "called_up_share_capital": "2000.00", "profit_loss_account_reserve": "1485.00", "shareholder_funds": "3485.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-April2016.zip" }, { "url": "/company/08346259/accounts/2015-01-31", "made_up_date": "2015-01-31", "period_start": "2015-01-31", "period_end": "2015-01-31", "entity_name": "Gore Bioscience Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "22101.00", "debtors": "2264.00", "cash_bank_in_hand": "7014.00", "current_assets": "9307.00", "creditors_due_within_one_year": "66540.00", "creditors_due_after_one_year": "12802.00", "net_current_assets_liabilities": "-57233.00", "total_assets_less_current_liabilities": "-35132.00", "net_assets_liabilities": "-47934.00", "called_up_share_capital": "2000.00", "profit_loss_account_reserve": "-49934.00", "shareholder_funds": "47934.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2015.zip" }, { "url": "/company/08346259/accounts/2014-01-31", "made_up_date": "2014-01-31", "period_start": "2014-01-31", "period_end": "2014-01-31", "entity_name": "Gore Bioscience Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "2268.00", "debtors": "33306.00", "cash_bank_in_hand": "18577.00", "current_assets": "51883.00", "creditors_due_within_one_year": "66307.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-14424.00", "total_assets_less_current_liabilities": "-12156.00", "net_assets_liabilities": "-12156.00", "called_up_share_capital": "2000.00", "profit_loss_account_reserve": "-14156.00", "shareholder_funds": "12156.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2015.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/08346259/filing-history" }, "confirmation_statement": { "next_due": "2027-07-19", "last_made_up": "2026-07-05" }, "officers": [ { "name": "CORNEY, Robert", "person_url": "/person/6355531", "role": "director", "appointed_on": "2015-01-30", "resigned_on": null, "nationality": "British", "occupation": "", "source": "stream", "retrieved_at": "2026-07-23T05:44:02+00:00" }, { "name": "GORE, Calum Derek", "person_url": "/person/6355532", "role": "director", "appointed_on": "2013-01-03", "resigned_on": null, "nationality": "English", "occupation": "", "source": "stream", "retrieved_at": "2026-07-23T05:44:02+00:00" } ], "psc": [ { "name": "Mr Robert Corney", "kind": "individual-person-with-significant-control", "person_url": "/person/4239130", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent", "voting-rights-25-to-50-percent" ], "notified_on": "2020-05-11", "ceased_on": null, "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Mr Calum Derek Gore", "kind": "individual-person-with-significant-control", "person_url": "/person/739001", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent", "voting-rights-25-to-50-percent" ], "notified_on": "2016-08-01", "ceased_on": null, "nationality": "English", "country_of_residence": "England", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-08-01", "retrieved_at": "2026-08-02T05:12:20.351914+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }